P. Rizzo

发表

Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer.

A. Nacci, L. Orlando, S. Cinieri, 2012, European journal of cancer.

Molecularly targeted endocrine therapies for breast cancer.

G. Colucci, E. Maiello, N. Fazio, 2010, Cancer treatment reviews.

Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer

M. Portaluri, L. Orlando, S. Cinieri, 2010, Oncology.

Hypovitaminosis D in Internal Medicine Inpatients

R. Gancia, P. D’Amelio, G. Isaia, 2007, Calcified Tissue International.

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women

P. Rizzo, V. Benedetto, E. Raffone, 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

S. Barni, R. Labianca, G. Luporini, 2005, Tumori.

Management of advanced breast cancer.

M. Colleoni, A. Cusmai, L. Orlando, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

First-line pemetrexed plus cisplatin followed by maintenance pemetrexed versus carboplatin-paclitaxel plus bevacizumab followed by maintenance bevacizumab (ERACLE) in advanced nonsquamous NSCLC: A quality-of-life-oriented, multicenter randomized phase III trial of the GOIM (Gruppo Oncologico Italia

D. Galetta, G. Colucci, E. Maiello, 2013 .

Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.

L. Orlando, S. Cinieri, N. Calvani, 2019, Future oncology.

Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis

M. Mencoboni, A. Addeo, G. Banna, 2018, Clinical and Translational Oncology.

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.

D. Galetta, G. Colucci, E. Maiello, 2015, Clinical lung cancer.

Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients

V. Lorusso, A. Nacci, L. Orlando, 2013, Journal of chemotherapy.

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

F. Cappuzzo, A. Rossi, D. Galetta, 2019, Clinical and Translational Oncology.

Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).

D. Galetta, G. Colucci, E. Maiello, 2011, Clinical lung cancer.

Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference.

A. Cusmai, L. Orlando, S. Cinieri, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].

P. Rizzo, J. Baldi, A. de Oliveira e Silva, 1996, Arquivos de gastroenterologia.

Discordance in pathology report after central pathology review in early breast cancer and its impact on treatment choice.

A. Nacci, L. Orlando, S. Cinieri, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

When less is better: the safety and efficacy of reduced intensity gemcitabine in a difficult patient population with advanced non-small-cell lung cancer

A. Nacci, L. Orlando, S. Cinieri, 2013, Medical Oncology.

Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer

M. Portaluri, L. Orlando, S. Cinieri, 2010, Oncology.